Why is ACROBiosystems Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 21.30% and Operating profit at -0.99% over the last 5 years
2
With a growth in Net Sales of 26.33%, the company declared Very Positive results in Mar 26
- OPERATING CASH FLOW(Y) Highest at CNY 530.69 MM
- DEBTORS TURNOVER RATIO(HY) Highest at 7.94 times
- RAW MATERIAL COST(Y) Fallen by -8.62% (YoY)
3
With ROE of 6.17%, it has a fair valuation with a 1.71 Price to Book Value
- Over the past year, while the stock has generated a return of -25.16%, its profits have risen by 27.1%
4
Underperformed the market in the last 1 year
- Even though the market (China Shanghai Composite) has generated returns of 16.78% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -25.16% returns
How much should you hold?
- Overall Portfolio exposure to ACROBiosystems Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is ACROBiosystems Co., Ltd. for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
ACROBiosystems Co., Ltd.
-25.16%
0.32
60.39%
China Shanghai Composite
16.78%
1.20
13.96%
Quality key factors
Factor
Value
Sales Growth (5y)
21.30%
EBIT Growth (5y)
-0.99%
EBIT to Interest (avg)
48.47
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.66
Sales to Capital Employed (avg)
0.25
Tax Ratio
4.17%
Dividend Payout Ratio
60.58%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
20.75%
ROE (avg)
6.17%
Valuation Key Factors 
Factor
Value
P/E Ratio
28
Industry P/E
Price to Book Value
1.71
EV to EBIT
28.60
EV to EBITDA
18.44
EV to Capital Employed
2.28
EV to Sales
3.84
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
7.99%
ROE (Latest)
6.17%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
Technical Movement
11What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 530.69 MM
DEBTORS TURNOVER RATIO(HY)
Highest at 7.94 times
RAW MATERIAL COST(Y)
Fallen by -8.62% (YoY
NET SALES(Q)
Highest at CNY 235.59 MM
-3What is not working for the Company
INVENTORY TURNOVER RATIO(HY)
Lowest at 0.53 times
DEBT-EQUITY RATIO
(HY)
Highest at -44.49 %
Here's what is working for ACROBiosystems Co., Ltd.
Debtors Turnover Ratio
Highest at 7.94 times and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Operating Cash Flow
Highest at CNY 530.69 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Net Sales
Highest at CNY 235.59 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Net Sales
At CNY 235.59 MM has Grown at 26.33%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Raw Material Cost
Fallen by -8.62% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for ACROBiosystems Co., Ltd.
Inventory Turnover Ratio
Lowest at 0.53 times and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Debt-Equity Ratio
Highest at -44.49 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio






